lunes, 3 de noviembre de 2025

Delaying CDK4/6 Inhibitor Treatment to Second Line Saves Costs, Maintains Outcomes in Advanced Breast Cancer Edited by Vineeta Teotia Medscape UK November 03, 2025

https://www.medscape.com/viewarticle/delaying-cdk4-6-inhibitor-treatment-second-line-saves-costs-2025a1000tp7

No hay comentarios:

Publicar un comentario